Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22902,94,1.03 [0.85-1.25],0.7499629085145691
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23531,176,1.02 [0.90-1.16],0.7623647311756865
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23299,1143,1.07 [1.03-1.12],0.0019804660154193
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23558,403,0.96 [0.87-1.05],0.3691825077079546
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22816,2986,1.03 [1.00-1.06],0.0282972329046985
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23032,2427,1.05 [1.02-1.09],0.0031166845267723
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23317,1164,1.02 [0.98-1.07],0.3354038525981552
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23463,78,1.01 [0.81-1.26],0.9216101871956032
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22001,693,1.07 [1.00-1.13],0.0377255199403824
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21251,788,1.11 [1.05-1.18],0.0003728897692363
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21301,217,1.02 [0.91-1.16],0.7025733637370242
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16502,1402,1.06 [1.01-1.11],0.0173340675383367
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21107,315,1.13 [1.05-1.23],0.0021957960333439
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23502,1349,1.02 [0.98-1.07],0.3480228212424695
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Mycoses,23611,456,0.99 [0.91-1.07],0.74087314305609
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22963,807,1.09 [1.04-1.16],0.0014303042621638
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23565,757,1.06 [1.00-1.13],0.0440821740152049
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22329,176,1.02 [0.90-1.16],0.7151374562896544
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23669,35,1.12 [0.85-1.48],0.4157982546663342
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23480,672,1.06 [0.99-1.12],0.0903764314694408
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23459,74,0.97 [0.80-1.17],0.7638949071832559
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23586,165,0.99 [0.89-1.10],0.8086143616896843
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23571,150,0.99 [0.88-1.10],0.7919058942979831
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22452,296,1.04 [0.95-1.14],0.374660554976498
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22381,225,1.03 [0.94-1.13],0.5849602258332949
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22251,98,1.05 [0.86-1.27],0.6367978563204533
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23646,35,0.90 [0.68-1.20],0.4671382692583764
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23601,140,1.03 [0.91-1.16],0.6359100792104577
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Viral warts,23503,42,1.08 [0.89-1.30],0.4402700067333557
RLN2,Prorelaxin H2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23532,71,0.97 [0.79-1.18],0.7282217723417732
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm,23431,203,0.98 [0.90-1.08],0.7464318976859579
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23580,59,1.06 [0.92-1.23],0.4177374332667883
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23572,59,1.03 [0.88-1.21],0.6848016393616947
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23419,1047,1.03 [0.98-1.08],0.275630547728462
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of meninges,23645,72,0.94 [0.75-1.18],0.6000829873742745
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23611,58,1.14 [0.95-1.36],0.1480859814099075
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23638,116,1.10 [0.97-1.26],0.1346239838803432
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm of ovary,23600,148,0.97 [0.86-1.09],0.6007475415144095
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23649,235,1.03 [0.92-1.14],0.6576447206374822
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Caecum,23655,216,0.96 [0.84-1.10],0.539380556398242
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23587,60,0.94 [0.75-1.19],0.6236905161737999
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23654,131,1.16 [1.04-1.30],0.0086751543967174
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Rectum,23615,240,1.10 [1.01-1.20],0.0286318632576573
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23574,441,1.01 [0.94-1.09],0.7239492460217325
RLN2,Prorelaxin H2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23654,250,1.08 [0.98-1.19],0.1161423583839953
RLN2,Prorelaxin H2,Chapter II Neoplasms,Carcinoma in situ of breast,19155,120,0.97 [0.86-1.10],0.668554455798654
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19225,138,0.97 [0.87-1.10],0.670173990644821
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19218,28,1.12 [0.87-1.43],0.3780642650259093
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19246,56,0.83 [0.57-1.20],0.3194000118534089
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23609,123,0.98 [0.85-1.13],0.8087033285614543
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Haemangioma, any site",23610,121,0.98 [0.85-1.14],0.8252544537718666
RLN2,Prorelaxin H2,Chapter II Neoplasms,Leiomyoma of uterus,22803,498,1.09 [1.05-1.13],3.887055279686927e-05
RLN2,Prorelaxin H2,Chapter II Neoplasms,Lung cancer and mesothelioma,16970,278,1.02 [0.91-1.15],0.7378976643750936
RLN2,Prorelaxin H2,Chapter II Neoplasms,Lymphoid leukaemia,19221,31,1.12 [0.87-1.43],0.3898071018924219
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19342,152,1.00 [0.90-1.12],0.9765574890354984
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19285,95,0.92 [0.72-1.16],0.4701644053557845
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19354,164,1.11 [1.00-1.25],0.059847783370019
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19252,62,1.08 [0.87-1.33],0.4857742235843402
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19253,63,1.18 [0.99-1.39],0.0624466322017841
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19238,48,0.68 [0.40-1.15],0.151314996273459
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19316,126,0.89 [0.73-1.09],0.2553553880047954
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19282,92,0.95 [0.76-1.19],0.6717381708364052
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19261,71,0.96 [0.77-1.19],0.6980733488158604
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19224,34,0.77 [0.49-1.20],0.2480673322724757
RLN2,Prorelaxin H2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19260,70,1.05 [0.89-1.25],0.562730148756183
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanocytic naevi,23439,205,1.03 [0.95-1.12],0.4756767008004235
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanocytic naevi of trunk,23630,69,1.12 [0.99-1.26],0.0616450581067647
RLN2,Prorelaxin H2,Chapter II Neoplasms,Melanoma in situ,19219,75,1.07 [0.89-1.30],0.4710168804790582
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19261,71,0.95 [0.75-1.21],0.6732359535661561
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19320,130,1.02 [0.87-1.19],0.8326701009539013
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19395,205,0.93 [0.78-1.11],0.431709982963751
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19270,80,1.05 [0.88-1.26],0.5594900137374847
RLN2,Prorelaxin H2,Chapter II Neoplasms,Other benign neoplasms of skin,23475,149,1.05 [0.95-1.17],0.3514882749593455
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19988,798,1.01 [0.95-1.08],0.7194314215972157
RLN2,Prorelaxin H2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20023,833,1.02 [0.96-1.09],0.4304307132496169
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23391,331,1.00 [0.92-1.08],0.9660876036732028
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21962,81,1.04 [0.82-1.31],0.7740121396182447
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23128,68,1.14 [0.99-1.31],0.0697397136055681
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22797,2543,1.06 [1.03-1.09],5.146875199494791e-05
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22273,28,1.10 [0.73-1.67],0.64039618639552
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23324,46,1.26 [1.06-1.49],0.0071524856769002
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23170,1289,1.08 [1.03-1.12],0.0008776785364002
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23170,1289,1.08 [1.03-1.12],0.0008776785364002
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21947,66,1.11 [0.95-1.30],0.2022610066509215
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23306,1061,1.06 [1.01-1.10],0.0196648445822211
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23379,101,1.07 [0.93-1.22],0.3379110939202058
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23107,47,0.93 [0.69-1.25],0.6242707511557758
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23112,52,1.13 [0.95-1.35],0.1607568281576251
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23487,209,1.08 [0.98-1.19],0.1123709683859545
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23573,54,1.02 [0.87-1.20],0.7637234649504455
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23456,178,1.05 [0.95-1.17],0.354235578233486
RLN2,Prorelaxin H2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22358,113,1.08 [0.94-1.23],0.2681964786065218
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,19124,206,1.08 [0.96-1.22],0.1823155997489245
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22433,60,0.99 [0.84-1.16],0.8613514140304313
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22429,56,1.03 [0.89-1.19],0.7111017176178602
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,18962,44,1.04 [0.80-1.35],0.76583805604561
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21710,52,0.87 [0.68-1.10],0.2355506433790607
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21414,202,1.06 [0.95-1.19],0.2939295492793483
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23290,418,1.09 [0.96-1.24],0.1931124398931057
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23130,258,1.28 [1.10-1.49],0.0011208235876996
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22931,59,0.79 [0.51-1.21],0.2730688623184439
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23339,1681,0.98 [0.95-1.02],0.2795518062239017
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20975,1644,0.98 [0.95-1.02],0.3478473801839519
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",18961,43,1.12 [0.91-1.38],0.2830199882793502
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21046,100,0.86 [0.67-1.09],0.2153530361095721
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19163,245,1.10 [0.99-1.22],0.0865253999245682
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,18960,42,0.92 [0.71-1.19],0.5260762816488547
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21595,2677,0.99 [0.96-1.03],0.7868064317405754
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,19098,180,1.03 [0.89-1.20],0.6752485782723237
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19389,471,1.05 [0.97-1.14],0.1903228757514194
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23586,307,1.05 [0.97-1.14],0.2632897126428267
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23421,142,1.05 [0.92-1.20],0.471775805394337
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,19004,86,1.06 [0.89-1.25],0.5314776868776165
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",18966,48,1.10 [0.88-1.37],0.3927279747330287
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22913,1967,1.00 [0.96-1.04],0.9220915992174488
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,19091,173,1.19 [1.05-1.34],0.005364417208406
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,19087,169,1.31 [1.17-1.47],4.53084619170392e-06
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19366,448,1.08 [0.99-1.18],0.0958632460990267
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,18988,70,1.02 [0.76-1.36],0.9083506456949296
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23417,138,1.05 [0.92-1.20],0.450003485605341
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19441,523,0.99 [0.89-1.10],0.8832627737285159
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19393,475,1.11 [1.03-1.19],0.0091123294425996
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21274,62,1.03 [0.86-1.24],0.754928960965844
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22920,4002,1.01 [0.98-1.04],0.5505260452171441
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21008,62,0.87 [0.67-1.12],0.2852840367073704
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21023,77,0.92 [0.76-1.12],0.4000495310459234
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23500,1766,0.98 [0.95-1.02],0.3645574088290151
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23504,1765,0.98 [0.95-1.02],0.3824037614005167
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21019,73,1.00 [0.81-1.23],0.9882547757313648
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23314,1369,1.00 [0.96-1.04],0.8604936638426859
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20192,1274,1.08 [1.03-1.13],0.0033666981305886
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23658,153,1.02 [0.88-1.19],0.7501807876535984
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22909,37,1.26 [0.96-1.66],0.0996537157622934
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22058,113,1.02 [0.90-1.17],0.7206328935843166
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22113,168,1.03 [0.91-1.16],0.689008449738413
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19134,216,1.02 [0.91-1.15],0.7604924708235655
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22096,119,1.03 [0.88-1.22],0.6953115058106623
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1474,37,1.02 [0.72-1.43],0.9175658312614692
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1565,146,1.09 [0.94-1.26],0.2724976176486854
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22000,23,1.27 [0.92-1.76],0.1458233203425878
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1459,23,1.07 [0.73-1.56],0.7400704093621123
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23262,1285,1.03 [0.98-1.08],0.2793384098006308
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23160,288,1.29 [1.11-1.49],0.0006127999272949
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21624,412,1.04 [0.97-1.13],0.2700186681412306
RLN2,Prorelaxin H2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19527,609,1.08 [1.00-1.16],0.0522576455072726
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23581,205,1.00 [0.89-1.14],0.9387788216493528
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22778,45,0.92 [0.59-1.42],0.7033441461579772
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Angina pectoris,22356,737,1.02 [0.95-1.10],0.5526184374505153
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22813,80,0.79 [0.55-1.15],0.2216764980161948
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22763,30,0.90 [0.49-1.64],0.7307812262686137
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22869,136,0.95 [0.76-1.18],0.6492605887544378
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15395,1267,1.04 [0.97-1.11],0.2295919290670836
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,AV-block,20747,212,1.12 [0.96-1.30],0.1505074951813785
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23629,259,0.98 [0.87-1.10],0.7033565884876232
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cardiac arrest,14232,104,1.08 [0.90-1.31],0.401327839569477
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20652,117,0.91 [0.74-1.11],0.3420622116307494
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20606,71,0.94 [0.75-1.16],0.5567120100094232
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23665,28,1.21 [0.91-1.60],0.1919149473033454
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Conduction disorders,21165,630,1.05 [0.97-1.14],0.211999652956396
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22876,1268,1.02 [0.96-1.08],0.5574972803200184
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21316,6291,1.01 [0.99-1.03],0.5126086383696866
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22379,218,1.02 [0.90-1.15],0.8069638999429402
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Endocarditis,20582,47,1.18 [0.95-1.45],0.1327238956440938
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23585,721,1.02 [0.94-1.12],0.5826552474344444
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypertension,21849,5281,1.02 [0.99-1.04],0.2065086158424392
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21857,5289,1.02 [0.99-1.04],0.1692808055148025
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23567,37,1.01 [0.74-1.37],0.9635401938351484
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16717,149,1.14 [0.99-1.32],0.0662107704331395
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16631,63,1.30 [1.08-1.55],0.0046525863807477
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Hypotension,23553,918,1.06 [1.00-1.12],0.0552187746721596
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23021,84,0.79 [0.56-1.14],0.2070462730157539
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23053,1434,1.00 [0.95-1.06],0.932337957832056
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23398,389,1.05 [0.95-1.17],0.3363775277092402
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,20799,264,0.93 [0.80-1.08],0.3517682507469576
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23478,522,1.00 [0.92-1.10],0.9458587755883168
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22037,418,1.02 [0.93-1.13],0.620045059221912
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23644,76,1.00 [0.78-1.30],0.9772488936779218
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23661,205,0.98 [0.84-1.14],0.7650943680648613
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22196,35,1.18 [0.93-1.49],0.1811638544738382
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other aneurysm,22783,50,0.97 [0.76-1.23],0.7717666796376501
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other arrhythmias,20846,311,1.07 [0.97-1.18],0.1565917897794531
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22794,61,0.94 [0.69-1.29],0.7097917619333819
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22904,171,1.12 [1.01-1.26],0.040322976667536
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20683,148,0.98 [0.85-1.14],0.7988923557408183
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22236,75,0.95 [0.76-1.18],0.6487078330299887
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22203,42,1.04 [0.85-1.27],0.7192962920823323
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22598,31,0.97 [0.63-1.51],0.908894050753682
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22296,135,1.02 [0.88-1.18],0.8213152309244917
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21203,668,1.09 [1.01-1.17],0.0265243634225321
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22672,37,0.98 [0.75-1.29],0.8823663742550774
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23179,446,1.04 [0.97-1.13],0.2743910910665248
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23171,280,1.13 [1.01-1.26],0.0269346806063395
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23030,463,0.98 [0.86-1.12],0.7653684741443337
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14376,248,1.04 [0.94-1.15],0.4747505179456205
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22966,245,1.13 [1.01-1.26],0.0345516500326402
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22444,283,1.03 [0.93-1.15],0.521743853328726
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23267,376,1.06 [0.97-1.16],0.211447042365941
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23600,490,1.00 [0.90-1.11],0.949561839556282
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20720,185,1.15 [1.01-1.30],0.0393177457347831
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23164,273,1.14 [1.02-1.27],0.021249380580233
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22699,132,1.14 [0.99-1.32],0.075734602268944
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23389,452,1.01 [0.91-1.12],0.878701076563868
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23366,492,1.02 [0.93-1.12],0.653682805769117
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22990,61,0.98 [0.78-1.22],0.8386104343874909
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22768,35,0.67 [0.36-1.22],0.1916380371135855
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23192,183,1.07 [0.93-1.22],0.3386037353949619
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23131,175,0.99 [0.84-1.16],0.8653337112545936
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Varicose veins,22539,378,1.06 [0.98-1.15],0.1295697182653437
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22742,82,1.05 [0.84-1.31],0.6552530804801828
RLN2,Prorelaxin H2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23484,596,1.03 [0.96-1.11],0.3890450156043407
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23633,195,1.01 [0.92-1.11],0.8381165414215739
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21034,1596,1.00 [0.97-1.04],0.8661858736171889
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Any mental disorder,23156,3718,1.00 [0.98-1.03],0.8247709022890355
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23608,231,1.00 [0.91-1.09],0.972495965071719
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21134,1696,0.98 [0.95-1.02],0.2860217769464985
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19514,76,1.12 [0.97-1.28],0.1159354505453681
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Smoking dependency,23315,1033,1.00 [0.96-1.05],0.8668232205419708
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20638,1200,1.00 [0.96-1.04],0.9723870272392056
RLN2,Prorelaxin H2,Chapter V Mental and behavioural disorders,Vascular dementia,23250,93,0.82 [0.54-1.23],0.3344455725680311
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Alzheimer disease,23667,320,1.20 [1.04-1.39],0.012032012953635
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",16205,51,0.75 [0.42-1.35],0.3411104543924705
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Bell's palsy,21816,70,0.99 [0.83-1.18],0.8856101291927482
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22301,555,0.92 [0.86-0.99],0.0321630643956907
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Cerebral cysts,23318,184,1.06 [0.96-1.16],0.2754694952430088
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23604,238,1.02 [0.90-1.16],0.7544541009549923
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23247,38,0.61 [0.34-1.12],0.1122295272985611
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23656,43,1.08 [0.89-1.32],0.4422827680708414
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23178,44,1.06 [0.85-1.33],0.5974182418115415
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Epilepsy,22405,239,0.95 [0.85-1.06],0.334136163042655
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23306,1140,1.00 [0.96-1.04],0.9953265092269784
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23623,298,0.99 [0.87-1.13],0.9290572881932968
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23138,2480,1.03 [0.99-1.06],0.1780894048600632
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23358,41,0.95 [0.73-1.24],0.7065935260733567
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Hemiplegia,23554,188,1.07 [0.94-1.22],0.3111284654616558
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Hydrocephalus,23188,54,1.08 [0.87-1.33],0.4926398766170269
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23651,63,1.11 [0.95-1.30],0.1974798961026854
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21854,108,0.94 [0.82-1.09],0.4169691634034633
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21799,53,1.18 [1.02-1.37],0.0308822325700281
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Memory loss,23139,95,1.08 [0.91-1.29],0.3739742430509213
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Migraine,22604,438,1.03 [0.98-1.09],0.2670637875453416
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23568,396,1.04 [0.98-1.10],0.2370112658401427
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Motor neuron disease,16295,116,0.93 [0.76-1.14],0.495434356457997
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23479,127,0.98 [0.88-1.08],0.6684766872784966
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22951,1205,0.98 [0.94-1.03],0.4016439358559943
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Neurological diseases,22281,3198,1.00 [0.97-1.03],0.93426696351078
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23334,125,1.08 [0.87-1.34],0.5106984806113433
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22115,369,1.02 [0.94-1.09],0.6881639197194094
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23617,197,1.05 [0.94-1.17],0.4133984613552723
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19149,578,1.09 [1.01-1.18],0.0209689943381199
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23193,59,0.97 [0.77-1.22],0.764692400715901
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23245,111,1.11 [0.98-1.25],0.1144692261747973
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23463,138,1.06 [0.90-1.25],0.4656055434124234
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21824,78,1.00 [0.85-1.17],0.9961062023009148
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other headache syndromes,22234,68,1.02 [0.87-1.19],0.8255360434588264
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other neurological diseases,23568,434,1.04 [0.97-1.11],0.265552210910155
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Other sleep disorders,22511,345,0.97 [0.90-1.05],0.4827735414756032
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Parkinson's disease,23644,140,1.08 [0.88-1.31],0.4690153299638456
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23206,72,0.98 [0.84-1.14],0.7981345332735696
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23666,72,1.08 [0.89-1.31],0.4389894411502083
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Sleep apnoea,23514,278,0.99 [0.91-1.08],0.9015836645776624
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23454,34,1.09 [0.82-1.45],0.5587791399340727
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23658,141,0.91 [0.76-1.08],0.2748936189672752
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21803,57,1.08 [0.89-1.33],0.4290112742051134
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23667,323,1.21 [1.05-1.39],0.0089506569631984
RLN2,Prorelaxin H2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23211,90,0.82 [0.54-1.25],0.3487094336712412
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23162,91,1.07 [0.85-1.34],0.5845195701907495
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23269,419,0.85 [0.74-0.99],0.0310578179011619
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23547,140,1.09 [0.95-1.24],0.2352883173610132
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22702,53,0.74 [0.50-1.09],0.1288673413770946
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22693,44,1.15 [1.00-1.33],0.0506923500755304
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23559,58,1.10 [0.88-1.38],0.386241580612673
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23414,144,0.98 [0.79-1.23],0.8787879468346096
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1466,29,1.12 [0.85-1.48],0.4130630680501826
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1748,56,1.11 [0.92-1.35],0.2786399464988258
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23155,84,0.82 [0.62-1.07],0.1409611802240886
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23516,904,0.97 [0.90-1.05],0.4252893329165874
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23298,649,1.00 [0.93-1.07],0.9089586571583448
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22911,262,0.93 [0.81-1.06],0.2551661842654699
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23593,743,0.85 [0.77-0.94],0.0009299154482151
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23657,62,1.01 [0.82-1.26],0.9101849931426066
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23524,674,0.84 [0.76-0.94],0.0015502204199076
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23629,359,0.91 [0.79-1.04],0.159726400147293
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23583,183,0.95 [0.82-1.12],0.5605263399725458
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22687,38,0.97 [0.63-1.49],0.8840085914902792
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22689,40,0.85 [0.52-1.40],0.5304643432200022
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22710,61,0.86 [0.63-1.18],0.3505248785659363
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23589,619,0.95 [0.86-1.05],0.3259357459113577
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23120,150,0.81 [0.64-1.04],0.1002189524713924
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22906,56,1.12 [0.86-1.45],0.4158127088745774
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23361,91,0.72 [0.50-1.03],0.0741113670965991
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23547,277,0.96 [0.83-1.11],0.5780027030974717
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23032,182,0.78 [0.65-0.95],0.012545372253167
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23520,120,0.93 [0.75-1.14],0.4662680140214859
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23375,405,1.00 [0.89-1.12],0.99581560042024
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23205,134,0.99 [0.86-1.14],0.9034648399313372
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22118,2203,0.93 [0.88-0.99],0.0176434931311118
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23512,242,0.92 [0.77-1.09],0.3331062778313258
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23647,139,1.01 [0.88-1.16],0.8918231945582675
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22987,338,0.96 [0.86-1.07],0.4778390469607585
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23329,59,0.69 [0.42-1.12],0.1302349720351416
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23643,48,0.94 [0.69-1.29],0.714939980916534
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22732,83,1.09 [0.90-1.32],0.3634188230398079
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22779,130,0.90 [0.75-1.08],0.257381365659727
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22705,93,0.95 [0.72-1.23],0.6811912310909349
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22909,59,0.97 [0.79-1.18],0.7245223575367841
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22669,57,0.83 [0.63-1.11],0.2072997072418948
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23073,103,0.79 [0.60-1.06],0.1191198724201637
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23124,154,1.00 [0.82-1.21],0.9899866841280814
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22761,112,1.01 [0.86-1.20],0.8755834388112735
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22694,82,0.80 [0.64-1.00],0.0453671483502995
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22671,59,1.05 [0.80-1.39],0.7084316936871755
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21717,1802,0.88 [0.82-0.95],0.0006989327207676
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22727,78,1.04 [0.87-1.24],0.6525933101833217
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23445,374,0.97 [0.88-1.07],0.5151000527482918
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23111,40,1.24 [0.95-1.62],0.1187354121449666
RLN2,Prorelaxin H2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23213,142,1.06 [0.93-1.21],0.3579841230848355
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23445,99,1.00 [0.84-1.19],0.9920481444555742
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23626,92,1.13 [1.00-1.27],0.0412515227262616
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23559,123,0.95 [0.84-1.08],0.4293227046717882
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23410,64,1.06 [0.88-1.29],0.5358325934892686
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23410,64,1.05 [0.89-1.25],0.5479659475556184
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23576,699,0.97 [0.90-1.05],0.5191050100323958
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23355,478,0.96 [0.87-1.07],0.4905718631421616
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22980,103,1.05 [0.89-1.24],0.5484372836011554
RLN2,Prorelaxin H2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22953,76,0.85 [0.66-1.10],0.2196396047349657
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23427,72,1.08 [0.95-1.23],0.2571494382257663
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23557,202,1.08 [1.00-1.16],0.0569491706382324
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23408,53,1.06 [0.91-1.22],0.4807080890078588
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,All influenza,22187,114,1.13 [0.99-1.30],0.0667714457595218
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22186,113,1.14 [1.00-1.31],0.0466150733405869
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),16806,114,1.06 [0.95-1.19],0.3213201364213215
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23549,245,0.98 [0.90-1.07],0.6417421023756505
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18345,1813,1.02 [0.99-1.05],0.2302597698574297
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18481,1789,1.02 [0.98-1.05],0.3705934603565124
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23311,116,1.12 [0.99-1.26],0.0672672578563755
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22136,63,1.06 [0.89-1.26],0.5129619766979926
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Bronchiectasis,20423,344,1.05 [0.95-1.17],0.3287254252027941
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20140,61,1.16 [0.97-1.38],0.106663812027899
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22665,2586,1.02 [0.99-1.05],0.137553123418378
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22564,57,1.05 [0.88-1.27],0.5728953420483442
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22634,127,0.88 [0.75-1.04],0.1295841433602213
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23516,901,1.02 [0.95-1.08],0.64418116347627
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22570,63,1.04 [0.87-1.23],0.6824939648747044
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21848,4446,1.04 [1.02-1.07],0.0001300370041168
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22796,289,1.03 [0.95-1.11],0.4679269966775227
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Early onset COPD,22897,282,0.95 [0.88-1.03],0.2032692574438157
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Emphysema,20309,230,0.98 [0.84-1.15],0.8457555981683754
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22217,204,1.24 [1.11-1.38],8.021200358051135e-05
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23490,1417,1.06 [1.02-1.11],0.0054854832175698
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22252,239,1.19 [1.08-1.31],0.0005175789834875
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Later onset COPD,22861,619,0.98 [0.87-1.12],0.7907920881369059
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23662,184,1.00 [0.85-1.18],0.9976405532164198
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Nasal polyp,22568,61,0.84 [0.66-1.08],0.1795315937034926
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23465,813,1.07 [1.01-1.13],0.0160088777015015
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23502,1513,1.07 [1.02-1.11],0.0040412002397594
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23185,678,1.01 [0.96-1.06],0.8233767479586549
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other pleural conditions,22024,35,0.86 [0.60-1.24],0.419590636657023
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23590,301,1.18 [1.09-1.28],8.307517791153537e-05
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23590,1029,1.07 [1.01-1.12],0.0194297445787095
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pleural effusion,22709,720,1.08 [1.02-1.15],0.0130411148313646
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pleural plaque,22029,40,1.00 [0.73-1.36],0.9878437836252726
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23276,1203,1.06 [1.01-1.12],0.017513211643664
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23634,156,1.00 [0.84-1.20],0.9785511240958472
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pneumothorax,22077,88,1.01 [0.82-1.26],0.9103800770193058
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pollen allergy,23646,207,0.99 [0.90-1.08],0.7899639941268963
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23341,52,1.27 [1.07-1.51],0.0057749397249861
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16733,41,1.09 [0.81-1.48],0.560432674482984
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23446,794,1.08 [1.02-1.14],0.0117705019311683
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22752,245,0.98 [0.90-1.07],0.6399788143830427
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Viral pneumonia,22258,185,1.04 [0.93-1.17],0.4874898953161202
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23319,145,1.03 [0.91-1.18],0.6080807356780215
RLN2,Prorelaxin H2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11391,91,1.11 [0.97-1.28],0.1310572705199036
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16919,34,1.08 [0.88-1.34],0.4599367806902498
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute appendicitis,23501,122,0.96 [0.85-1.08],0.5011854450134052
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute gastritis,17772,70,1.10 [0.94-1.29],0.2370330070348077
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21701,141,1.01 [0.88-1.15],0.9274593631562283
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Acute peritonitis,23170,72,1.09 [0.94-1.26],0.24660497276826
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22925,33,0.94 [0.73-1.21],0.6473327047180384
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Barrett oesophagus,18002,300,0.98 [0.88-1.08],0.6583106006102251
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21630,70,0.92 [0.69-1.22],0.561821803574919
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23301,70,0.91 [0.68-1.22],0.5190183896047047
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Cholecystitis,21715,155,1.12 [1.01-1.25],0.0309124553829975
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Cholelithiasis,22583,1023,1.01 [0.97-1.06],0.6600782288237639
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Chronic gastritis,17992,290,0.99 [0.89-1.10],0.8445646470877394
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21597,37,1.01 [0.80-1.29],0.9201103690683188
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23597,67,1.18 [1.01-1.37],0.0368802433564812
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Coeliac disease,22343,127,0.99 [0.87-1.13],0.8907828960044517
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Collagenous colitis,22020,95,1.11 [0.95-1.30],0.1984118040199474
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23544,137,1.01 [0.90-1.13],0.9220780916691544
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Constipation,23380,1458,1.01 [0.96-1.05],0.7121425106606283
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Crohn disease,22000,75,1.04 [0.90-1.20],0.6123082709262228
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23354,52,1.00 [0.81-1.24],0.972955666973208
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22001,76,1.01 [0.87-1.18],0.873095145844691
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Dental caries,22950,196,1.03 [0.95-1.12],0.4801593799887064
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22240,2101,1.03 [0.99-1.06],0.1554896045487356
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of appendix,23537,158,0.98 [0.88-1.08],0.6339710178831113
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of liver,23580,688,1.02 [0.96-1.08],0.549497474290273
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21680,3978,0.98 [0.96-1.01],0.2193721591125103
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23263,509,1.02 [0.97-1.08],0.4129141076216709
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23565,467,1.06 [1.00-1.12],0.0627088108350199
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22859,105,0.94 [0.81-1.09],0.424122104286982
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22728,57,0.99 [0.82-1.19],0.9001280603201248
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23415,1199,1.02 [0.98-1.06],0.3609906300652626
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diseases of tongue,22729,89,0.88 [0.73-1.05],0.1649949221663765
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22926,1366,1.01 [0.97-1.05],0.7059603173097351
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19643,2758,1.00 [0.97-1.04],0.8502644770191897
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17819,117,1.15 [1.01-1.31],0.0401696557323445
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23618,97,1.11 [0.95-1.30],0.2016023817912928
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23584,56,1.10 [0.99-1.23],0.0729131918957879
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22977,85,1.16 [1.00-1.34],0.0451882909712261
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16985,100,0.95 [0.83-1.08],0.422293143867149
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18287,585,1.03 [0.97-1.09],0.4045606569936344
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastric ulcer,17998,296,0.98 [0.89-1.09],0.7437348228102669
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20104,2402,0.99 [0.96-1.03],0.6964932299640227
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18112,410,1.03 [0.95-1.11],0.4792253727359505
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18501,7234,1.00 [0.98-1.01],0.7307088203888896
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,GI-bleeding,23172,956,1.00 [0.95-1.05],0.8917660846534231
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22813,59,0.79 [0.58-1.06],0.1201702747163544
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17731,1091,0.98 [0.94-1.03],0.465793749041533
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22925,33,0.97 [0.68-1.40],0.8821005892241458
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Hernia,22624,2485,1.03 [1.00-1.06],0.0411086276612157
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Impacted teeth,23592,51,1.08 [0.96-1.21],0.2267725688661242
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Impaction of intestines,16942,57,1.09 [0.89-1.34],0.4181205852989097
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Inguinal hernia,20287,148,1.02 [0.87-1.19],0.8250784105065667
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16969,84,0.99 [0.81-1.20],0.8981634446069557
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22370,154,1.08 [0.97-1.19],0.1438534321890844
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17584,699,0.97 [0.92-1.02],0.2642606117708505
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23655,302,1.01 [0.93-1.10],0.7621572111686163
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22633,708,1.00 [0.95-1.06],0.8896671747764762
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22876,951,1.00 [0.95-1.05],0.8802871005029964
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17834,132,1.07 [0.93-1.23],0.3237165672297267
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oesophagitis,18197,495,1.01 [0.93-1.09],0.8635796010817026
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23626,134,1.00 [0.88-1.14],0.9891497755491888
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20193,54,1.17 [0.98-1.39],0.0846316213088805
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17972,1087,0.99 [0.94-1.03],0.6000350932706293
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21811,251,0.97 [0.86-1.10],0.6832085388495746
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21723,163,1.01 [0.90-1.13],0.8881793629224439
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18262,1377,0.96 [0.92-1.00],0.0746666097398133
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21787,4902,0.99 [0.96-1.01],0.2679385325774745
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22729,197,0.95 [0.84-1.07],0.4165073068413788
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of liver,23462,570,1.01 [0.94-1.08],0.7957322615992853
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18220,518,1.01 [0.94-1.08],0.849843315138342
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21693,133,1.00 [0.83-1.20],0.9795244749309604
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23510,412,1.05 [0.99-1.12],0.1141379382068915
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18632,930,0.97 [0.91-1.02],0.2509619389364201
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23189,973,1.00 [0.95-1.05],0.9875847280054044
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22907,153,0.88 [0.75-1.03],0.1015250039793109
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18394,1509,1.01 [0.97-1.05],0.6949063355933955
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19502,1800,0.99 [0.96-1.03],0.7382445796660869
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22983,91,1.09 [0.94-1.25],0.2440302061936941
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22763,838,1.01 [0.96-1.07],0.6725116877320789
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17170,285,1.05 [0.96-1.16],0.2970629067034993
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23575,65,1.09 [0.98-1.21],0.1099027597278568
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17311,426,0.99 [0.91-1.08],0.8052546074974268
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22335,119,1.12 [1.00-1.25],0.0468993013998608
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23659,61,0.90 [0.72-1.12],0.3461692134746549
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22754,109,0.95 [0.82-1.10],0.462534316651073
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Toxic colitis,21980,55,1.08 [0.83-1.40],0.5518336021036396
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17911,209,1.00 [0.87-1.14],0.96808926894879
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22074,149,0.95 [0.83-1.07],0.3910027008263685
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22051,126,0.99 [0.88-1.12],0.8954323236592434
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Umbilical hernia,20293,154,1.06 [0.96-1.18],0.2575670706572264
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,17049,164,1.04 [0.90-1.20],0.556602254809452
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Ventral hernia,20357,218,1.06 [0.97-1.17],0.2029200954304468
RLN2,Prorelaxin H2,Chapter XI Diseases of the digestive system,Volvulus,16960,75,0.86 [0.69-1.08],0.1895106623077983
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23594,214,1.03 [0.90-1.17],0.6865903089015483
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23392,75,1.01 [0.88-1.18],0.8471258671814093
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21884,192,0.99 [0.89-1.09],0.7828252324889203
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23196,546,1.03 [0.96-1.11],0.3670648566193641
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22778,128,0.97 [0.85-1.10],0.6183827962406674
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21968,276,1.08 [0.95-1.22],0.2415339384621654
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23390,239,1.05 [0.96-1.14],0.314866517296186
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23566,415,1.02 [0.95-1.09],0.6460982376615104
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23196,45,1.08 [0.91-1.29],0.375823591028796
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22288,2737,1.01 [0.98-1.04],0.3789447724771433
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23283,400,1.00 [0.94-1.07],0.971913336655373
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23157,274,0.98 [0.91-1.07],0.7047200516560301
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23386,736,1.00 [0.94-1.07],0.951226438329039
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23649,66,0.85 [0.65-1.11],0.228906418439725
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21777,85,1.11 [0.96-1.29],0.1524726562959662
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22921,38,1.03 [0.83-1.29],0.7635855059789993
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23376,225,1.04 [0.96-1.14],0.3460071441177349
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22058,366,1.04 [0.96-1.13],0.3241121446863078
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21740,48,0.92 [0.67-1.27],0.6186994548691125
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23576,67,1.07 [0.90-1.27],0.4303592682478977
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22786,136,0.96 [0.81-1.13],0.5986460482703229
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23466,149,1.03 [0.91-1.17],0.6337953579300183
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23192,41,1.29 [1.01-1.66],0.0430715430889845
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21748,56,1.10 [0.92-1.32],0.2830742412575695
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23079,1387,1.05 [1.00-1.09],0.0343764776555885
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22088,396,1.05 [0.97-1.13],0.1953259335508032
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21744,52,1.02 [0.80-1.30],0.8802022544502484
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23595,278,1.01 [0.92-1.10],0.8552302685120641
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23226,75,0.87 [0.69-1.10],0.2595042491360259
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23532,215,1.03 [0.94-1.14],0.4909154591601576
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23621,241,1.03 [0.92-1.17],0.5741424849956515
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21831,139,0.93 [0.82-1.06],0.2807890062878579
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21920,228,1.04 [0.93-1.16],0.460539850228635
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23610,230,1.03 [0.91-1.17],0.604001984437078
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21870,178,1.27 [1.14-1.42],1.680726425632884e-05
RLN2,Prorelaxin H2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23635,126,1.01 [0.88-1.16],0.8416315074068786
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20197,114,1.03 [0.93-1.15],0.5523516248323791
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21484,5504,0.98 [0.96-1.00],0.0623839304564302
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20278,4298,0.97 [0.94-1.00],0.04743432706602
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20150,67,0.93 [0.78-1.10],0.3775420722135317
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20293,137,1.02 [0.91-1.15],0.714316397839931
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20337,181,0.93 [0.81-1.06],0.2546157114373149
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23421,103,0.99 [0.87-1.12],0.8330408434422022
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20259,103,0.90 [0.67-1.21],0.4921990996192927
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17177,1197,0.99 [0.93-1.05],0.6415528185219678
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23536,199,1.00 [0.86-1.16],0.9692411483351426
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20656,500,0.95 [0.86-1.05],0.2762063916317576
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19872,7006,0.99 [0.97-1.01],0.2512403348901307
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21189,115,1.04 [0.90-1.20],0.6122693688250405
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20201,118,0.97 [0.82-1.15],0.7482987132031876
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20682,599,0.97 [0.91-1.03],0.3308705078813642
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22772,2616,1.02 [0.99-1.05],0.1641934325472439
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20237,154,0.81 [0.68-0.96],0.0148592847855193
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20420,337,0.98 [0.91-1.05],0.5321369016371711
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20234,151,1.04 [0.95-1.15],0.3846410654484911
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22805,89,1.04 [0.84-1.30],0.6984926619107357
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17599,1619,0.99 [0.94-1.04],0.6076162734191919
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16158,178,1.29 [1.15-1.45],1.132647438000453e-05
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23654,175,1.29 [1.15-1.44],1.787260562489294e-05
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16072,92,1.01 [0.88-1.16],0.9049494191882688
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16484,504,0.98 [0.91-1.05],0.5301756801088655
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20374,291,1.02 [0.95-1.10],0.5240601662496625
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16528,548,0.99 [0.93-1.05],0.679459839079354
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20214,58,1.18 [0.94-1.49],0.1512467775667183
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20774,618,1.02 [0.96-1.09],0.5016118512460244
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20447,291,1.02 [0.94-1.11],0.6603983010866307
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16490,510,1.00 [0.94-1.06],0.934339094923651
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20155,72,0.98 [0.85-1.15],0.8384682130587623
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20145,62,0.85 [0.67-1.09],0.1996899789427861
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21119,45,1.01 [0.80-1.29],0.9139716768010512
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23255,2181,0.97 [0.93-1.02],0.2133165209268175
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22639,1565,0.92 [0.87-0.98],0.0087956114796046
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23484,518,1.00 [0.93-1.08],0.9939921008816244
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18598,2618,0.97 [0.93-1.01],0.1032802972516971
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16039,59,0.96 [0.80-1.14],0.6376146894179502
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20172,89,1.05 [0.91-1.21],0.5325443250270592
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16021,41,0.95 [0.60-1.49],0.819764593690909
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16157,177,0.78 [0.64-0.94],0.0110540537622703
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21334,260,1.03 [0.95-1.12],0.4658641471992626
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21570,496,1.01 [0.93-1.10],0.7736796404413305
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23645,96,0.88 [0.71-1.09],0.2529435876094367
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21919,1763,1.01 [0.98-1.05],0.4606670518673611
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20197,114,0.89 [0.77-1.03],0.1245925519321194
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16185,205,1.03 [0.92-1.14],0.6405883737144691
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20855,699,1.03 [0.97-1.09],0.3906697503982439
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18189,2209,0.98 [0.95-1.02],0.3550413152182025
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22827,111,0.97 [0.80-1.18],0.7873339201320242
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23649,73,1.02 [0.88-1.19],0.7801663850728291
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20151,68,0.98 [0.81-1.18],0.8054984802832591
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21360,1277,1.02 [0.98-1.06],0.3950863261628453
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20154,71,0.97 [0.79-1.20],0.7934841253400842
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17701,1721,0.98 [0.93-1.02],0.327865394512706
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21201,127,1.04 [0.92-1.18],0.4948449737460367
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20132,49,0.78 [0.58-1.06],0.1107697328942446
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20329,173,0.97 [0.84-1.12],0.6874714155078023
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20582,499,1.06 [0.99-1.14],0.082475866828384
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23162,446,0.97 [0.88-1.07],0.5390788677262923
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20713,557,1.02 [0.95-1.09],0.5627982801576911
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23496,501,1.02 [0.95-1.10],0.5640316595451574
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23642,57,1.11 [0.91-1.34],0.2963184752959318
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20277,194,0.91 [0.80-1.03],0.1284439776549306
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18144,792,0.96 [0.90-1.02],0.1839977464185353
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20657,574,1.04 [0.98-1.11],0.1927051907497444
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20188,105,0.85 [0.68-1.05],0.1225370548424818
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16052,72,0.98 [0.78-1.23],0.8785645302434569
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18272,2292,0.98 [0.95-1.02],0.4370340236820884
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16710,730,0.97 [0.90-1.04],0.3911285592474979
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22968,252,1.01 [0.85-1.20],0.9271139761912108
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23618,69,0.94 [0.74-1.20],0.6329948943698641
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21691,48,1.25 [1.01-1.54],0.0395501006004699
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16054,74,1.02 [0.88-1.19],0.7813189836283853
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20253,97,1.01 [0.86-1.18],0.9089886541005404
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16501,521,1.00 [0.93-1.08],0.9154467462659112
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20364,281,0.94 [0.85-1.05],0.3042741901683934
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20402,246,1.04 [0.95-1.14],0.403195033205173
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20392,236,0.98 [0.85-1.13],0.740888018448853
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18254,78,0.89 [0.72-1.12],0.3209836772359657
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23648,63,1.11 [0.92-1.34],0.2874152722927203
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20633,550,1.01 [0.95-1.07],0.6987451559866447
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22866,150,0.92 [0.79-1.06],0.2551910328378214
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22525,2442,1.00 [0.97-1.03],0.8990824001536043
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20219,136,1.02 [0.89-1.17],0.7866021878584287
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20635,479,1.00 [0.92-1.09],0.9799273844302272
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22143,224,0.99 [0.89-1.11],0.8876030331473417
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20368,212,0.85 [0.71-1.01],0.0694895306755228
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21663,1507,1.02 [0.98-1.07],0.3514131214489163
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21181,1025,1.02 [0.96-1.08],0.5081313548863967
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20139,56,1.10 [0.93-1.30],0.2701857681949182
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22929,213,1.04 [0.96-1.14],0.3277386201294952
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20257,174,0.97 [0.86-1.09],0.566673332565881
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20197,114,0.97 [0.81-1.15],0.7183380753614323
RLN2,Prorelaxin H2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16025,45,1.08 [0.85-1.38],0.5409689050790176
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22824,1030,1.11 [1.05-1.17],0.0003469955403095
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17718,85,1.03 [0.93-1.14],0.559340642770018
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23071,100,1.14 [1.05-1.25],0.0024461689612032
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23529,198,1.01 [0.90-1.12],0.9196996545881956
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23353,22,0.53 [0.24-1.16],0.1103267817676365
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22948,1154,1.19 [1.13-1.25],7.554274876372109e-11
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23527,58,1.42 [1.17-1.72],0.0004178055483787
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23495,205,1.07 [0.94-1.21],0.2934216573655934
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Cystitis,20917,220,1.04 [0.93-1.16],0.5126365340744321
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Dialysis,21838,44,1.23 [1.03-1.46],0.0208597865214875
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23253,282,1.08 [1.01-1.15],0.0158055931615234
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17781,148,1.02 [0.95-1.10],0.5631385474565138
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17968,335,1.07 [1.03-1.11],0.0006937306927375
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18486,853,1.01 [0.95-1.06],0.8346353040988471
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18387,4260,1.05 [1.03-1.07],3.553947545933214e-06
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23521,52,1.05 [0.88-1.25],0.5875608289702755
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21677,180,0.98 [0.87-1.11],0.769589691381752
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23187,344,1.03 [0.96-1.09],0.4267142380475114
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23269,107,1.04 [0.97-1.12],0.2272695622777236
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17895,262,1.08 [1.04-1.13],0.000230734685961
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20760,63,0.99 [0.80-1.22],0.9001800788457035
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19722,2089,1.03 [1.00-1.05],0.0481935635197262
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17754,121,1.02 [0.93-1.11],0.7147241676972858
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23658,57,1.21 [1.03-1.43],0.0223816434725776
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23658,71,1.04 [0.86-1.27],0.6726418422299799
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22582,1885,1.06 [1.02-1.09],0.0036721714041869
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21106,409,0.91 [0.82-1.01],0.0739079308486977
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23070,99,0.92 [0.78-1.07],0.2806089738214699
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23616,326,1.12 [1.03-1.22],0.0088103801623192
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23613,76,0.90 [0.72-1.12],0.3423871137404962
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22312,1615,1.07 [1.03-1.11],0.0003919483056897
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23022,179,1.07 [0.99-1.16],0.0819967690756451
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17765,132,0.98 [0.87-1.11],0.7814254163369735
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17967,334,1.03 [0.97-1.10],0.2873850693545614
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17736,103,0.85 [0.71-1.03],0.0918250081030697
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17815,182,0.99 [0.89-1.10],0.8397898327349144
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21723,226,1.04 [0.94-1.14],0.4608309799370487
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23396,106,1.18 [1.03-1.35],0.0162214517236695
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17883,250,0.95 [0.88-1.04],0.2636230010801954
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17723,90,1.03 [0.94-1.14],0.5127673036346345
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18176,543,1.01 [0.97-1.06],0.5864954162615046
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17770,137,1.08 [0.96-1.22],0.1965766801526669
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18137,504,1.00 [0.94-1.05],0.8676542393855211
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23502,33,0.94 [0.69-1.28],0.6922427861547917
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23511,2014,1.11 [1.07-1.15],1.3685824339148566e-07
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21641,144,0.98 [0.87-1.09],0.6825292011935493
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21879,85,1.18 [1.00-1.40],0.0526000361469006
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23362,31,1.03 [0.83-1.28],0.7823537339058575
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20821,124,0.94 [0.80-1.11],0.4759538546313613
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23560,229,1.02 [0.92-1.12],0.7399051815646813
RLN2,Prorelaxin H2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17751,118,0.98 [0.89-1.09],0.7208938979261081
